Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Grown Rogue InternationalGRUSF -2.22%45 PS Ratio is 3.41 as of Jul. 17, 2026, which is 2% above its 10-year median of 3.33. GuruFocus rates GRUSF with a GF Score™ of 45/100 and a GF Value™ of $0.45 (Fairly Valued). The stock has 7 warning signs investors should review. Among 954 Drug Manufacturers companies, Grown Rogue International ranks worse than 63.73% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Grown Rogue International's share price is $0.437.
Grown Rogue International's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.13. Hence, Grown Rogue International's PS Ratio for today is 3.41.
The historical rank and industry rank for Grown Rogue International's PS Ratio or its related term are showing as below:
GRUSF'
s PS Ratio Range Over the Past 10 Years
Min: 0.56 Med: 3.33 Max: 462
Current: 3.44
During the past 13 years, Grown Rogue International's highest PS Ratio was 462.00. The lowest was 0.56. And the median was 3.33.
GRUSF's PS Ratio is ranked worse than 63.73% of 954
companies
in the Drug Manufacturers industry
Industry Median: 2.325
vs GRUSF: 3.44
During the past 13 years, Grown Rogue International's highest 3-Year average Revenue per Share Growth Rate was 292.40% per year. The lowest was -75.20% per year. And the median was 26.80% per year.
Back to Basics: PS Ratio
Grown Rogue International (OTCPK:GRUSF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Grown Rogue International PS Ratio Related Terms
Grown Rogue International PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Grown Rogue International's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grown Rogue International PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grown Rogue International's PS Ratio distribution charts can be found below:
* The bar in red indicates where Grown Rogue International's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Grown Rogue International's Share Price of today is $0.437. Grown Rogue International's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.13.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Grown Rogue International (GRUSF) has a PS Ratio of 3.41 as of Jul. 17, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Grown Rogue International and its competitors. This is near median its historical median of 3.33. Over the past decade, Grown Rogue International's PS Ratio has ranged from 0.56 to 462.00. According to the industry distribution chart, Grown Rogue International ranks #608 out of 954 companies in the Drug Manufacturers industry, placing it in the top 63.7%.
Is Grown Rogue International's PS Ratio too high?
Grown Rogue International's current PS Ratio of 3.41 is near median its 10-year median of 3.33. Over the past 10 years, this metric has ranged from a low of 0.56 to a high of 462.00. The Drug Manufacturers industry median PS Ratio is 2.33. Grown Rogue International's value of 3.41 is 46.7% above this industry median. Based on the distribution chart, Grown Rogue International ranks #608 out of 954 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Grown Rogue International has a GF Score™ of 45/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Grown Rogue International's PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Grown Rogue International ranks #608 out of 954 companies for PS Ratio. This places Grown Rogue International in the lower half of its industry. The industry median PS Ratio is 2.33. Grown Rogue International's value of 3.41 is 46.7% above this benchmark. Historically, Grown Rogue International's own PS Ratio has ranged from 0.56 to 462.00 over the past decade. While the company's 10-year median is 3.33 vs. the industry median of 2.33, Grown Rogue International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.33, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grown Rogue International's current PS Ratio of 3.41 is 46.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Grown Rogue International and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grown Rogue International's current PS Ratio is 3.41, which is near median its own 10-year median of 3.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grown Rogue International stock overvalued right now?
Based on GuruFocus' analysis, Grown Rogue International (GRUSF) is currently considered Fairly Valued. The stock's GF Value™ is $0.45, compared to a current price of $0.44 — trading 2.9% below its estimated fair value. The current PS Ratio is 3.41, which is near median its 10-year median of 3.33 and 46.7% above the Drug Manufacturers industry median of 2.33. Grown Rogue International's overall GF Score™ is 45/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Grown Rogue International (GRUSF), the current PS Ratio is 3.41 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grown Rogue International (GRUSF) Overvalued in 2026?
Based on GuruFocus' analysis, Grown Rogue International stock appears to be undervalued.
The current stock price of $0.44 is trading 2.9% below its estimated GF Value™ of $0.45.
GuruFocus considers Grown Rogue International to be Fairly Valued.
Key valuation signals for GRUSF:
PS Ratio: 3.41 (near median its 10-year median of 3.33)
GF Value™: $0.45 vs. price of $0.44 (2.9% below fair value)
Industry Position: 46.7% above the Drug Manufacturers median (#608 of 954)
No single metric tells the full story. See the GRUSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grown Rogue International Inc is engaged in the business of growing and selling cannabis products. Its primary cannabis product produced and sold is cannabis flower. Geographically, the company generates a majority of its revenue from the United States. The company has identified three operating segments: the Oregon segment represents cannabis production and sales activities in Oregon; the Michigan segment represents cannabis production and sales activities in Michigan; and the New Jersey segment represents cannabis production and sales activities in New Jersey.
45GF Score
Get the complete analysis for GRUSF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRUSF has been successfully added to your 
